Xu Y - Search Results

1

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy.

Yu M, Chen Z, Zhou Q, Zhang B, Huang J, Jin L, Zhou B, Liu S, Yan J, Li X, Zhang W, Liu C, Hu B, Fu P, Zhou C, Xu Y, Xiao Y, Zhou J, Fan J, Ren N, Hung MC, Guo L, Li H, Ye Q. Yu M, et al. Among authors: xu y. J Hepatol. 2022 Jul;77(1):140-151. doi: 10.1016/j.jhep.2022.01.026. Epub 2022 Feb 12. J Hepatol. 2022. PMID: 35157958

2

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.

Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J. Cai MY, et al. Clin Cancer Res. 2009 Jul 15;15(14):4686-93. doi: 10.1158/1078-0432.CCR-09-0463. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584149

3

Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.

Dai CX, Gao Q, Qiu SJ, Ju MJ, Cai MY, Xu YF, Zhou J, Zhang BH, Fan J. Dai CX, et al. BMC Cancer. 2009 Dec 1;9:418. doi: 10.1186/1471-2407-9-418. BMC Cancer. 2009. PMID: 19948069 Free PMC article.

4

PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection.

Xu YF, Yi Y, Qiu SJ, Gao Q, Li YW, Dai CX, Cai MY, Ju MJ, Zhou J, Zhang BH, Fan J. Xu YF, et al. J Hepatol. 2010 Nov;53(5):872-9. doi: 10.1016/j.jhep.2010.05.019. Epub 2010 Jul 15. J Hepatol. 2010. PMID: 20739083

5

Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.

Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS, Xu YF. Li YW, et al. J Hepatol. 2011 Mar;54(3):497-505. doi: 10.1016/j.jhep.2010.07.044. Epub 2010 Oct 1. J Hepatol. 2011. PMID: 21112656

6

RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.

Ji S, Xu J, Zhang B, Yao W, Xu W, Wu W, Xu Y, Wang H, Ni Q, Hou H, Yu X. Ji S, et al. Among authors: xu w, xu y, xu j. Cancer Biol Ther. 2012 Feb 15;13(4):206-15. doi: 10.4161/cbt.13.4.18692. Cancer Biol Ther. 2012. PMID: 22354009 Free article.

7

Management of a malignant case of solid pseudopapillary tumor of pancreas: a case report and literature review.

Ji S, Xu J, Zhang B, Xu Y, Liu C, Long J, Ni Q, Yu X. Ji S, et al. Among authors: xu y, xu j. Pancreas. 2012 Nov;41(8):1336-40. doi: 10.1097/MPA.0b013e31824d52c7. Pancreas. 2012. PMID: 22699200 Review.

8

B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence.

Sun TW, Gao Q, Qiu SJ, Zhou J, Wang XY, Yi Y, Shi JY, Xu YF, Shi YH, Song K, Xiao YS, Fan J. Sun TW, et al. Among authors: xu yf. Cancer Immunol Immunother. 2012 Nov;61(11):2171-82. doi: 10.1007/s00262-012-1278-5. Epub 2012 May 22. Cancer Immunol Immunother. 2012. PMID: 22729558 Free PMC article.

9

Application of "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy for normal soft pancreas cases.

Zhang B, Xu J, Liu C, Long J, Liu L, Xu Y, Wu C, Luo G, Ni Q, Li M, Yu X. Zhang B, et al. Among authors: xu y, xu j. Sci Rep. 2013;3:2068. doi: 10.1038/srep02068. Sci Rep. 2013. PMID: 23797701 Free PMC article.

10

Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.

Wang WQ, Liu L, Xu HX, Luo GP, Chen T, Wu CT, Xu YF, Xu J, Liu C, Zhang B, Long J, Tang ZY, Yu XJ. Wang WQ, et al. PLoS One. 2013 Aug 5;8(8):e71189. doi: 10.1371/journal.pone.0071189. Print 2013. PLoS One. 2013. PMID: 23940715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,088 results

Search Page

Filters